Abstract
Gastric ECL-cell hyperplasia and carcinoids (ECLoma) develop after 1 year in rats treated with omeprazole or 2 months in Mastomys treated with loxtidine. The aim of this study was to examine the ultrastructure of ECL cells in Mastomys after loxtidine treatment with an attempt to evaluate whether an impairment of autophagy was involved in the tumorigenesis. Mastomys were given loxtidine for 8 or 27 weeks. Morphological analysis of ECL cells showed that (1) cell size was not increased after 8 or 27 weeks; (2) secretory vesicles, a hallmark feature of welldifferentiated ECL cells, were unchanged after 8 weeks but reduced after 27 weeks; (3) granules were reduced after 8 or 27 weeks; (4) microvesicles were unchanged after the treatment; and (5) vacuoles and lipofuscin bodies were found occasionally after 8 weeks but not at 27 weeks. In addition, the appearance of ECL-cell ultrastructure differed between loxtidine-treated Mastomys and rats treated with omeprazole or subjected to antrectomy, but was similar between Mastomys treated with loxtidine for 27 weeks and mice deficient in CCK2 receptor. We suggest that the ultrastructure of ECL cells in Mastomys after long-term treatment with loxtidine displayed an impaired formation of vacuoles and lipofuscin bodies, markers of the autophagic pathway.
Similar content being viewed by others
References
Chen D, Zhao CM, Lindström E, Håkanson R (1999) Rat stomach ECL cells up-date of biology and physiology. Gen Pharmacol 32:413–422
Kidd M, Modlin IM, Tang LH (1998) Gastrin and the enterochromaffin-like cell: an acid update. Dig Surg 15:209–217
Waldum HL, Kleveland PM, Brenna E, Bakke I, Qvigstad G, Martinsen TC, Fossmark R, Gustafsson BI, Sandvik AK (2009) Interactions between gastric acid secretagogues and the localization of the gastrin receptor. Scand J Gastroenterol 44:390–393
Havu N (1986) Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35(suppl 1):42–55
Modlin IM, Lawton GP, Tang LH, Geibel J, Abraham R, Darr U (1994) The mastomys gastric carcinoid: aspects of enterochromaffin-like cell function. Digestion 55(suppl 3):31–37
Håkanson R, Sundler F (1990) Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis. Eur J Clin Invest 20(suppl 1):S65–S71
Waldum HL, Brenna E, Kleveland PM, Sandvik AK (1995) Gastrin-physiological and pathophysiological role: clinical consequences. Dig Dis 13:25–38
Modlin IM, Lye KD, Kidd M (2003) Carcinoid tumors of the stomach. Surg Oncol 12:153–172
Waldum HL, Aase S, Kvetnoi I, Brenna E, Sandvik AK, Syversen U, Johnsen G, Vatten L, Polak JM (1998) Neuroendocrine differentiation in human gastric carcinoma. Cancer (Phila) 83:435–444
Kimura K, Chen D, Lindström E, Yamada H, Zhao CM, Håkanson R (1997) Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia. Regul Pept 72:69–77
Chen D, Zhao CM, Yamada H, Norlen P, Håkanson R (1998) Novel aspects of gastrin-induced activation of histidine decarboxylase in rat stomach ECL cells. Regul Pept 77:169–175
Zhao CM, Bakke I, Tostrup-Skogaker N, Waldum HL, Håkanson R, Chen D (2001) Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats. Cell Tissue Res 303:415–422
Håkanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F (1993) Time-dependent changes in enterochromaffinlike cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 105:15–21
Andersson K, Zhao CM, Chen D, Sundler F, Hakanson R (1996) Effect of alpha-fluoromethylhistidine-evoked histamine depletion on ultrastructure of endocrine cells in acid-producing mucosa of stomach in mouse, rat and hamster. Cell Tissue Res 286:375–384
Nilsson O, Wangberg B, Johansson L, Modlin IM, Ahlman H (1992) Praomys (Mastomys) natalensis: a model for gastric carcinoid formation. Yale J Biol Med 65:741–751; discussion 827–829
Tang LH, Modlin IM, Lawton GP, Kidd M, Chinery R (1996) The role of transforming growth factor alpha in the enterochromaffinlike cell tumor autonomy in an African rodent, Mastomys. Gastroenterology 111:1212–1223
Tang LH, Luque EA, Efstathiou JA, Bortecen KH, Kidd M, Tarasova NI, Modlin IM (1997) Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent. Regul Pept 72:9–18
Lauffer JM, Tang LH, Zhang T, Hinoue T, Rahbar S, Odo M, Modlin IM, Kidd M (2001) PACAP mediates the neural proliferative pathway of Mastomys enterochromaffin-like cell transformation. Regul Pept 102:157–164
Kidd M, Hinoue T, Eick G, Lye KD, Mane SM, Wen Y, Modlin IM (2004) Global expression analysis of ECL cells in Mastomys natalensis gastric mucosa identifies alterations in the AP-1 pathway induced by gastrin-mediated transformation. Physiol Genomics 20:131–142
Kidd M, Siddique ZL, Drozdov I, Gustafsson BI, Camp RL, Black JW, Boyce M, Modlin IM (2010) The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development. Regul Pept 162:52–60
Wängberg B, Nilsson O, Theodorsson E, Modlin IM, Dahlstrom A, Ahlman H (1995) Are enterochromaffinlike cell tumours reversible? An experimental study on gastric carcinoids induced in Mastomys by histamine2-receptor blockade. Regul Pept 56:19–33
Kölby L, Wängberg B, Ahlman H, Modlin IM, Nilsson O (1998) Histamine metabolism of gastric carcinoids in Mastomys natalensis. Yale J Biol Med 71:207–215
Sundler F, Carlsson E, Hakanson R, Larsson H, Mattsson H (1986) Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats. Scand J Gastroenterol Suppl 118:39–46
Chen D, Zhao CM, Andersson K, Sundler F, Håkanson R (1996) Ultrastructure of enterochromaffin-like cells in rat stomach: effects of alpha-fluoromethylhistidine-evoked histamine depletion and hypergastrinemia. Cell Tissue Res 283:469–478
Zhao CM, Chen D, Lintunen M, Panula P, Håkanson R (1999) Effects of reserpine on ECL-cell ultrastructure and histamine compartmentalization in the rat stomach. Cell Tissue Res 295:131–140
Zhao CM, Chen D, Lintunen M, Panula P, Håkanson R (1999) Secretory organelles in ECL cells of the rat stomach: an immunohistochemical and electron-microscopic study. Cell Tissue Res 298:457–470
Chen D, Zhao CM, Al-Haider W, Hakanson R, Rehfeld JF, Kopin AS (2002) Differentiation of gastric ECL cells is altered in CCK(2) receptor-deficient mice. Gastroenterology 123:577–585
Zhao CM, Chen D, Andersson K, Hakanson R (1998) ECL cells of the rat stomach: development of lipofuscin in response to sustained gastrin stimulation. Cell Tissue Res 291:315–323
Essner E, Novikoff AB (1960) Human hepatocellular pigments and lysosomes. J Ultrastruct Res 3:374–391
Miyawaki H (1965) Histochemistry and electron microscopy of iron-containing granules, lysosomes, and lipofuscin in mouse mammary glands. J Natl Cancer Inst 34:601–623
Brun A, Brunk U (1970) Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J Histochem Cytochem 18:820–827
Terman A, Brunk UT (1998) Lipofuscin: mechanisms of formation and increase with age. APMIS 106:265–276
Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Trimmer C, Tsirigos A, Migneco G, Witkiewicz AK, Balliet R, Mercier I, Wang C, Flomenberg N, Howell A, Lin Z, Caro J, Pestell RG, Sotgia F, Lisanti MP (2010) The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: a simple solution to the autophagy paradox. Cell Cycle 9:4297–4306
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vigen, R.A., Kidd, M., Modlin, I.M. et al. Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine. Med Mol Morphol 45, 80–85 (2012). https://doi.org/10.1007/s00795-011-0544-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00795-011-0544-5